Original
Mejoría del perfil de lípidos y la función endotelial con fenofibrato en pacientes con síndrome metabólico y nivel de C-LDL dentro del objetivo terapéutico
Improvement of the lipid profile and endothelial function with fenofibrate in patients with metabolic syndrome and C-LDL level within the therapeutic goal
Sonia María López Correaa, Virginia Angélica Robinson Fuentesb, Elik Enrique Alonso Muñozc, Saúl Rojas Perezc, Jaime Carranza Madrigala,
Autor para correspondencia
a Escuela de Enfermería y Salud Pública, Universidad Michoacana de San Nicolás de Hidalgo, México
b División de Estudios de Postgrado, Facultad de Ciencias Médicas y Biológicas Dr. Ignacio Chávez, Universidad Michoacana de San Nicolás de Hidalgo, México
c Centro Unión de Diagnóstico Médico, Morelia, Michoacán, México
Leído
3923
Vecesse ha leído el artículo
674
Total PDF
3249
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 0 | 3 | 3 |
| 2025 10 | 0 | 3 | 3 |
| 2025 9 | 0 | 4 | 4 |
| 2025 8 | 0 | 5 | 5 |
| 2025 7 | 0 | 2 | 2 |
| 2025 6 | 0 | 5 | 5 |
| 2025 5 | 0 | 1 | 1 |
| 2025 3 | 0 | 2 | 2 |
| 2025 2 | 0 | 3 | 3 |
| 2025 1 | 0 | 1 | 1 |
| 2024 12 | 0 | 1 | 1 |
| 2024 11 | 0 | 3 | 3 |
| 2024 7 | 0 | 1 | 1 |
| 2024 5 | 0 | 5 | 5 |
| 2024 4 | 0 | 3 | 3 |
| 2024 3 | 0 | 4 | 4 |
| 2024 1 | 0 | 2 | 2 |
| 2023 12 | 0 | 3 | 3 |
| 2023 11 | 0 | 2 | 2 |
| 2023 10 | 0 | 3 | 3 |
| 2023 9 | 0 | 1 | 1 |
| 2023 8 | 0 | 4 | 4 |
| 2023 7 | 0 | 7 | 7 |
| 2023 6 | 0 | 5 | 5 |
| 2023 5 | 1 | 5 | 6 |
| 2023 4 | 0 | 6 | 6 |
| 2023 3 | 0 | 4 | 4 |
| 2023 2 | 0 | 1 | 1 |
| 2022 1 | 0 | 4 | 4 |
| 2022 12 | 0 | 5 | 5 |
| 2022 11 | 0 | 3 | 3 |
| 2022 10 | 0 | 2 | 2 |
| 2022 9 | 0 | 14 | 14 |
| 2022 7 | 0 | 5 | 5 |
| 2022 5 | 0 | 1 | 1 |
| 2022 4 | 0 | 8 | 8 |
| 2022 3 | 0 | 3 | 3 |
| 2021 1 | 0 | 1 | 1 |
| 2021 12 | 0 | 1 | 1 |
| 2021 10 | 0 | 2 | 2 |
| 2021 9 | 0 | 3 | 3 |
| 2021 8 | 0 | 2 | 2 |
| 2021 7 | 0 | 6 | 6 |
| 2021 6 | 0 | 1 | 1 |
| 2021 5 | 0 | 7 | 7 |
| 2021 4 | 0 | 19 | 19 |
| 2021 3 | 0 | 3 | 3 |
| 2021 2 | 0 | 6 | 6 |
| 2020 1 | 0 | 4 | 4 |
| 2020 12 | 0 | 2 | 2 |
| 2020 11 | 0 | 4 | 4 |
| 2020 9 | 0 | 1 | 1 |
| 2020 8 | 0 | 6 | 6 |
| 2020 7 | 0 | 2 | 2 |
| 2020 5 | 0 | 2 | 2 |
| 2020 4 | 0 | 2 | 2 |
| 2020 3 | 0 | 4 | 4 |
| 2020 2 | 0 | 3 | 3 |
| 2020 1 | 0 | 3 | 3 |
| 2019 12 | 0 | 2 | 2 |
| 2019 11 | 0 | 3 | 3 |
| 2019 10 | 0 | 1 | 1 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 1 | 1 |
| 2019 6 | 0 | 3 | 3 |
| 2019 5 | 0 | 19 | 19 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 20 | 4 | 24 |
| 2018 3 | 8 | 5 | 13 |
| 2018 2 | 12 | 7 | 19 |
| 2018 1 | 6 | 5 | 11 |
| 2017 12 | 11 | 5 | 16 |
| 2017 11 | 8 | 7 | 15 |
| 2017 10 | 8 | 0 | 8 |
| 2017 9 | 11 | 5 | 16 |
| 2017 8 | 16 | 3 | 19 |
| 2017 7 | 26 | 2 | 28 |
| 2017 6 | 20 | 11 | 31 |
| 2017 5 | 16 | 13 | 29 |
| 2017 4 | 22 | 9 | 31 |
| 2017 3 | 17 | 4 | 21 |
| 2017 2 | 19 | 11 | 30 |
| 2016 1 | 19 | 4 | 23 |
| 2016 12 | 23 | 8 | 31 |
| 2016 11 | 58 | 18 | 76 |
| 2016 10 | 54 | 12 | 66 |
| 2016 9 | 40 | 8 | 48 |
| 2016 8 | 24 | 2 | 26 |
| 2016 7 | 51 | 4 | 55 |
| 2016 6 | 38 | 18 | 56 |
| 2016 5 | 40 | 18 | 58 |
| 2016 4 | 17 | 21 | 38 |
| 2016 3 | 20 | 15 | 35 |
| 2016 2 | 18 | 8 | 26 |
| 2015 1 | 37 | 14 | 51 |
| 2015 12 | 40 | 17 | 57 |
| 2015 11 | 34 | 14 | 48 |
| 2015 10 | 38 | 18 | 56 |
| 2015 9 | 46 | 15 | 61 |
| 2015 8 | 32 | 14 | 46 |
| 2015 7 | 43 | 13 | 56 |
| 2015 6 | 74 | 6 | 80 |
| 2015 5 | 102 | 12 | 114 |
| 2015 4 | 45 | 9 | 54 |
| 2015 3 | 64 | 8 | 72 |
| 2015 2 | 41 | 3 | 44 |
| 2015 1 | 53 | 3 | 56 |
| 2014 12 | 83 | 7 | 90 |
| 2014 11 | 52 | 5 | 57 |
| 2014 10 | 97 | 4 | 101 |
| 2014 9 | 64 | 3 | 67 |
| 2014 8 | 67 | 3 | 70 |
| 2014 7 | 80 | 8 | 88 |
| 2014 6 | 69 | 7 | 76 |
| 2014 5 | 57 | 4 | 61 |
| 2014 4 | 67 | 3 | 70 |
| 2014 3 | 42 | 2 | 44 |
| 2014 2 | 56 | 2 | 58 |
| 2014 1 | 51 | 4 | 55 |
| 2011 1 | 1192 | 0 | 1192 |
Mostrar todo